Dr Joseph J Boyle

Publications


Journals

  • Boyle JJ; Johns M; Kampfer T; Nguyen AT; Game L; Schaer DJ; Mason JC; Haskard DO. (6 Jan 2012). Activating transcription factor 1 directs mhem atheroprotective macrophages through coordinated iron handling and foam cell protection. Circ Res. 110:20-33. DOI.
  • Neilan M; Boyle J; Lawrie A; Francis S; Haskard D; Qwarnstrom E. (Oct 2011). THE ROLE OF TILRR IN VASCULAR CELL INFLAMMATION AND DEVELOPMENT OF ATHEROSCLEROSIS. HEART. 97:6-7. DOI.
  • Boyle JJ; Johns M; Lo J; Chiodini A; Ambrose N; Evans PC; Mason JC; Haskard DO. (Nov 2011). Heme induces heme oxygenase 1 via Nrf2: role in the homeostatic macrophage response to intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. 31:2685-2691. DOI.
  • Haywood MEK; Rose J; Boyle J; McDermott AM; Rankin JM; Izui S; Walport MJ; Morley BJ. (Apr 2004). GENETIC DISSECTION OF BXSB LUPUS PHENOTYPE USING MICE CONGENIC FOR CHROMOSOME 1 DEMONSTRATES THAT SEPARATE INTERVALS DIRECT DIFFERENT ASPECTS OF DISEASE. RHEUMATOLOGY. 43:24-24.
  • Iqbal MB; Boyle JJ; Laffan MA; Haskard DO. (Jul 2010). DEXAMETHASONE EXERTS DUAL ACTIONS IN REDUCING MONOCYTE THROMBOGENIC PROFILE BY ENHANCING FIBRINOLYTIC ACTIVITY AND REDUCING PROCOAGULANT ACTIVITY. CLIN EXP RHEUMATOL. 28:S156-S156.
  • Direskeneli H; Boyle J; Ozdemir F; Yilmaz V; Eksioglu-Demiralp E; Haskard D; Saruhan-Direskeneli G. (Jul 2010). IDENTIFICATION OF JAK1 AS A CANDIDATE INFLAMMATORY SIGNALLING PATHWAY BY GENOME-WIDE EXPRESSION PROFILING IN MONOCYTES FROM PATIENTS WITH BEHCET'S DISEASE. CLIN EXP RHEUMATOL. 28:S108-S108.
  • Sperone A; Dryden NH; Birdsey GM; Madden L; Johns M; Evans PC; Mason JC; Haskard DO; et alBoyle JJ; Paleolog EM; Randi AM. (Jan 2011). The transcription factor Erg inhibits vascular inflammation by repressing NF-kappaB activation and proinflammatory gene expression in endothelial cells. Arterioscler Thromb Vasc Biol. 31:142-150. DOI.
  • Malik TH; Cortini A; Carassiti D; Boyle JJ; Haskard DO; Botto M. (9 Nov 2010). The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation. 122:1948-1956. DOI.
  • Stangou M; Bhangal G; Lai PC; Smith J; Keith JC; Boyle JJ; Pusey CD; Cook T; et alTam FW. (Jan 2011). Effect of IL-11 on glomerular expression of TGF-beta and extracellular matrix in nephrotoxic nephritis in Wistar Kyoto rats. J Nephrol. 24:106-111.
  • Chan CF; Keenan NG; Nielles-Vallespin S; Gatehouse P; Sheppard MN; Boyle JJ; Pennell DJ; Firmin DN. (2010). Ultra-short echo time cardiovascular magnetic resonance of atherosclerotic carotid plaque. J Cardiovasc Magn Reson. 12:17. DOI.
  • Keenan NG; Sheppard MN; Grasso A; Chan CF; Mukherjee RK; Boyle JJ; Gatehouse PD; Firmin DN; et alPennell DJ. (Apr 2010). Validation of carotid arterial wall volume measurement by cardiovascular magnetic resonance. J Magn Reson Imaging. 31:935-941. DOI.
  • Abdul-Salam VB; Ramrakha P; Krishnan U; Owen DR; Shalhoub J; Davies AH; Tang TY; Gillard JH; et alBoyle JJ; Wilkins MR; Edwards RJ. (May 2010). Identification and assessment of plasma lysozyme as a putative biomarker of atherosclerosis. Arterioscler Thromb Vasc Biol. 30:1027-1033. DOI.
  • Gaemperli O; Boyle JJ; Rimoldi OE; Mason JC; Camici PG. (Jun 2010). Molecular imaging of vascular inflammation. Eur J Nucl Med Mol Imaging. 37:1236. DOI.
  • Chaudhury H; Zakkar M; Boyle J; Cuhlmann S; van der Heiden K; Luong LEA; Davis J; Platt A; et alMason JC; Krams R; Haskard DO; Clark AR; Evans PC. (Mar 2010). c-Jun N-terminal kinase primes endothelial cells at atheroprone sites for apoptosis. Arterioscler Thromb Vasc Biol. 30:546-553. DOI.
  • Ali F; Ali NS; Bauer A; Boyle JJ; Hamdulay SS; Haskard DO; Randi AM; Mason JC. (1 Mar 2010). PPARdelta and PGC1alpha act cooperatively to induce haem oxygenase-1 and enhance vascular endothelial cell resistance to stress. Cardiovasc Res. 85:701-710. DOI.
  • Leung VWY; Yun S; Botto M; Mason JC; Malik TH; Song WC; Paixao-Cavalcante D; Pickering MC; et alBoyle JJ; Haskard DO. (Oct 2009). Decay-Accelerating Factor Suppresses Complement C3 Activation and Retards Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. AM J PATHOL. 175:1757-1767. DOI.
  • Lewis MJ; Malik TH; Ehrenstein MR; Boyle JJ; Botto M; Haskard DO. (4 Aug 2009). Immunoglobulin M Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. CIRCULATION. 120:417-U101. DOI.
  • Ali F; Zakkar M; Karu K; Lidington EA; Hamdulay SS; Boyle JJ; Zloh M; Bauer A; et alHaskard DO; Evans PC; Mason JC. (10 Jul 2009). Induction of the cytoprotective enzyme heme oxygenase-1 by statins is enhanced in vascular endothelium exposed to laminar shear stress and impaired by disturbed flow. J Biol Chem. 284:18882-18892. DOI.
  • Boyle JJ; Harrington HA; Piper E; Elderfield K; Stark J; Landis RC; Haskard DO. (Mar 2009). Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am J Pathol. 174:1097-1108. DOI.
  • Lutz J; Luong LA; Strobl M; Deng MH; Huang H; Anton M; Zakkar M; Enesa K; et alChaudhury H; Haskard DO; Baumann M; Boyle J; Harten S; Maxwell PH; Pusey C; Heemann U; Evans PC. (Dec 2008). The A20 gene protects kidneys from ischaemia/reperfusion injury by suppressing pro-inflammatory activation. J MOL MED-JMM. 86:1329-1339. DOI.
  • Yun S; Leung VW; Botto M; Boyle JJ; Haskard DO. (Oct 2008). Brief report: accelerated atherosclerosis in low-density lipoprotein receptor-deficient mice lacking the membrane-bound complement regulator CD59. Arterioscler Thromb Vasc Biol. 28:1714-1716. DOI.
  • Haskard DO; Boyle JJ; Mason JC. (Oct 2008). The role of complement in atherosclerosis. Curr Opin Lipidol. 19:478-482. DOI.
  • Enesa K; Ito K; Luong LEA; Thorbjornsen I; Phua C; To Y; Dean J; Haskard DO; et alBoyle J; Adcock I; Evans PC. (4 Jul 2008). Hydrogen peroxide prolongs nuclear localization of NF-kappaB in activated cells by suppressing negative regulatory mechanisms. J Biol Chem. 283:18582-18590. DOI.
  • Kinderlerer AR; Ali F; Johns M; Lidington EA; Leung V; Boyle JJ; Hamdulay SS; Evans PC; et alHaskard DO; Mason JC. (23 May 2008). KLF2-dependent, shear stress-induced expression of CD59 - A novel cytoprotective mechanism against complement-mediated injury in the vasculature. J BIOL CHEM. 283:14636-14644. DOI.
  • Rogers NJ; Gabriel L; Nunes CT; Rose SJ; Thiruudaian V; Boyle J; Morley BJ. (Dec 2007). Monocytosis in BXSB mice is due to epistasis between Yaa and the telomeric region of chromosome 1 but does not drive the disease process. Genes Immun. 8:619-627. DOI.
  • Ali F; Hamdulay SS; Kinderlerer AR; Boyle JJ; Lidington EA; Yamaguchi T; Soares MP; Haskard DO; et alRandi AM; Mason JC. (Dec 2007). Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1. J THROMB HAEMOST. 5:2537-2546.
  • Steinberg R; Harari OA; Lidington EA; Boyle JJ; Nohadani M; Samarel AM; Ohba M; Haskard DO; et alMason JC. (2 Nov 2007). A protein kinase C epsilon-anti-apoptotic kinase signaling complex protects human vascular endothelial cells against apoptosis through induction of Bcl-2. J BIOL CHEM. 282:32288-32297. DOI.
  • Elkington PT; Green JA; Emerson JE; Lopez-Pascua LD; Boyle JJ; O'Karre CM; Friedland JS. (Oct 2007). Synergistic up-regulation of epithelial cell matrix metalloproteinase-9 secretion in tuberculosis. AM J RESP CELL MOL. 37:431-437. DOI.
  • Butler M; Boyle JJ; Powell JJ; Playford RJ; Ghosh S. (Sep 2007). Dietary microparticles implicated in Crohn's disease can impair macrophage phagocytic activity and act as adjuvants in the presence of bacterial stimuli. Inflamm Res. 56:353-361. DOI.
  • Hepburn AL; Lampert IA; Boyle JJ; Horncastle D; Ng WF; Layton M; Vyse TJ; Botto M; et alMason JC. (Aug 2007). In vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosus. ANN RHEUM DIS. 66:1106-1109. DOI.
  • Alzetani M; Boyle JJ; Lefroy D; Nihoyannopoulos P. (3 Jul 2007). Images in cardiovascular medicine. An unusual site for a common disease. Circulation. 116:e1. DOI.
  • Rankin J; Boyle JJ; Rose SJ; Gabriel L; Lewis M; Thiruudaian V; Rogers NJ; Izui S; et alMorley BJ. (1 Apr 2007). The Bxs6 locus of BXSB mice is sufficient for high-level expression of gp70 and the production of gp70 immune complexes. J Immunol. 178:4395-4401.
  • O'Kane CM; Boyle JJ; Horncastle DE; Elkington PT; Friedland JS. (15 Mar 2007). Monocyte-dependent fibroblast CXCL8 secretion occurs in tuberculosis and limits survival of mycobacteria within macrophages. J Immunol. 178:3767-3776.
  • Bhatia VK; Yun S; Leung V; Grimsditch DC; Benson GM; Botto MB; Boyle JJ; Haskard DO. (Jan 2007). Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice. Am J Pathol. 170:416-426. DOI.
  • Tuladhar SM; Noursadeghi M; Boyle JJ; Friedland JS; Hornick P. (Oct 2006). Tuberculous pericardial effusion after coronary artery bypass graft. Ann Thorac Surg. 82:1519-1521. DOI.
  • Cibrian D; Ajamieh H; Berlanga J; Leon OS; Alba JS; Kim MJT; Marchbank T; Boyle JJ; et alFreyre F; Del Barco DG; Lopez-Saura P; Guillen G; Ghosh S; Goodlad RA; Playford RJ. (May 2006). Use of growth-hormone-releasing peptide-6 (GHRP-6) for the prevention of multiple organ failure. CLIN SCI. 110:563-573. DOI.
  • Aitman TJ; Dong R; Vyse TJ; Norsworthy PJ; Johnson MD; Smith J; Mangion J; Roberton-Lowe C; et alMarshall AJ; Petretto E; Hodges MD; Bhangal G; Patel SG; Sheehan-Rooney K; Duda M; Cook PR; Evans DJ; Domin J; Flint J; Boyle JJ; Pusey CD; Cook HT. (16 Feb 2006). Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature. 439:851-855. DOI.
  • Elkington PT; Nuttall RK; Boyle JJ; O'Kane CM; Horncastle DE; Edwards DR; Friedland JS. (15 Dec 2005). Mycobacterium tuberculosis, but not vaccine BCG, specifically upregulates matrix metalloproteinase-1. Am J Respir Crit Care Med. 172:1596-1604. DOI.
  • Elkington PT; Emerson JE; Lopez-Pascua LD; O'Kane CM; Horncastle DE; Boyle JJ; Friedland JS. (15 Oct 2005). Mycobacterium tuberculosis up-regulates matrix metalloproteinase-1 secretion from human airway epithelial cells via a p38 MAPK switch. J Immunol. 175:5333-5340.
  • Edwards RJ; Taylor GW; Ferguson M; Murray S; Rendell N; Wrigley A; Bai Z; Boyle J; et alFinney SJ; Jones A; Russell HH; Turner C; Cohen J; Faulkner L; Sriskandan S. (1 Sep 2005). Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes. J Infect Dis. 192:783-790. DOI.
  • Summers SA; Dorling A; Boyle JJ; Shaunak S. (Aug 2005). Cure of disseminated cryptococcal infection in a renal allograft recipient after addition of gamma-interferon to anti-fungal therapy. Am J Transplant. 5:2067-2069. DOI.
  • Brown M; Noursadeghi M; Boyle J; Davidson RN. (Jul 2005). Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis. Br J Dermatol. 153:203-205. DOI.
  • Boyle JJ. (Jan 2005). Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. Curr Vasc Pharmacol. 3:63-68.
  • Haywood ME; Rogers NJ; Rose SJ; Boyle J; McDermott A; Rankin JM; Thiruudaian V; Lewis MR; et alFossati-Jimack L; Izui S; Walport MJ; Morley BJ. (1 Oct 2004). Dissection of BXSB lupus phenotype using mice congenic for chromosome 1 demonstrates that separate intervals direct different aspects of disease. J Immunol. 173:4277-4285.
  • Lee NJ; Rigby RJ; Gill H; Boyle JJ; Fossati-Jimack L; Morley BJ; Vyse TJ. (Oct 2004). Multiple loci are linked with anti-red blood cell antibody production in NZB mice -- comparison with other phenotypes implies complex modes of action. Clin Exp Immunol. 138:39-46. DOI.
  • Boyle JJ. (Sep 2004). Human macrophages kill human mesangial cells by Fas-L-induced apoptosis when triggered by antibody via CD16. Clin Exp Immunol. 137:529-537. DOI.
  • FitzGerald AJ; Pu M; Marchbank T; Westley BR; May FE; Boyle J; Yadollahi-Farsani M; Ghosh S; et alPlayford RJ. (May 2004). Synergistic effects of systemic trefoil factor family 1 (TFF1) peptide and epidermal growth factor in a rat model of colitis. Peptides. 25:793-801. DOI.
  • Rigby RJ; Rozzo SJ; Boyle JJ; Lewis M; Kotzin BL; Vyse TJ. (1 Apr 2004). New loci from New Zealand Black and New Zealand White mice on chromosomes 4 and 12 contribute to lupus-like disease in the context of BALB/c. J Immunol. 172:4609-4617.
  • Barakat MT; Ashrafian H; Todd JF; Boyle JJ; Lynn JA; Williams GR. (Apr 2004). Renal magnesium loss causing hypomagnesaemia and autonomous hyperparathyroidism. Nephrol Dial Transplant. 19:977-980. DOI.
  • Cooke FJ; Terpos E; Boyle J; Rahemtulla A; Rogers TR. (Dec 2003). Disseminated Aspergillus terreus infection arising from cutaneous inoculation treated with caspofungin. Clin Microbiol Infect. 9:1238-1241.
  • Sullivan DC; Huminiecki L; Moore JW; Boyle JJ; Poulsom R; Creamer D; Barker J; Bicknell R. (21 Nov 2003). EndoPDI, a novel protein-disulfide isomerase-like protein that is preferentially expressed in endothelial cells acts as a stress survival factor. J Biol Chem. 278:47079-47088. DOI.
  • Boyle JJ; Weissberg PL; Bennett MR. (1 Sep 2003). Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms. Arterioscler Thromb Vasc Biol. 23:1553-1558. DOI.
  • Boyle J. (May 2003). Histological measurement of tumour angiogenesis. EUR J CANCER. 39:859-860. DOI.
  • Soilleux EJ; Morris LS; Trowsdale J; Coleman N; Boyle JJ. (Dec 2002). Human atherosclerotic plaques express DC-SIGN, a novel protein found on dendritic cells and macrophages. J Pathol. 198:511-516. DOI.
  • Boyle JJ; Weissberg PL; Bennett MR. (1 Oct 2002). Human macrophage-induced vascular smooth muscle cell apoptosis requires NO enhancement of Fas/Fas-L interactions. Arterioscler Thromb Vasc Biol. 22:1624-1630.
  • Boyle JJ. (Sep 2002). A non-isotopic fluorescence microscopy assay-for human macrophage-mesangial cell ADCC identifies Fc-gamma -RIII, phospholipase C and Fas-L mediated apoptosis. J AM SOC NEPHROL. 13:97A-97A.
  • Boyle JJ; Smith J; Pusey CD; Cook HT. (Sep 2002). Susceptibility of WKY rats to glomerulonephritis is associated with enhanced macrophage killing of mesangial cells mediated via nitric oxide and phospholipase C. J AM SOC NEPHROL. 13:49A-49A.
  • Berlanga J; Prats P; Remirez D; Gonzalez R; Lopez-Saura P; Aguiar J; Ojeda M; Boyle JJ; et alFitzgerald AJ; Playford RJ. (Aug 2002). Prophylactic use of epidermal growth factor reduces ischemia/reperfusion intestinal damage. Am J Pathol. 161:373-379. DOI.
  • Boyle JJ; Bowyer DE; Weissberg PL; Bennett MR. (Sep 2001). Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-ligand/Fas interactions. Arterioscler Thromb Vasc Biol. 21:1402-1407.
  • Greaves DR; Häkkinen T; Lucas AD; Liddiard K; Jones E; Quinn CM; Senaratne J; Green FR; et alTyson K; Boyle J; Shanahan C; Weissberg PL; Gordon S; Ylä-Hertualla S. (Jun 2001). Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 21:923-929.
  • Boyle JJ; Wilson B; Bicknell R; Harrower S; Weissberg PL; Fan TP. (Oct 2000). Expression of angiogenic factor thymidine phosphorylase and angiogenesis in human atherosclerosis. J Pathol. 192:234-242. DOI.
  • Boyle JJ. (Aug 1999). Vascular smooth muscle cell apoptosis in atherosclerosis. Int J Exp Pathol. 80:197-203.
  • Bennett MR; Boyle JJ. (May 1998). Apoptosis of vascular smooth muscle cells in atherosclerosis. Atherosclerosis. 138:3-9.
  • Bennett MR; Macdonald K; Chan SW; Boyle JJ; Weissberg PL. (6 Apr 1998). Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ Res. 82:704-712.
  • Bennett MR; Boyle JJ. (Mar 1998). Apoptosis in cardiovascular disease. Heart. 79:313.
  • Jenkins JT; Boyle JJ; McKay IC; Richens D; McPhaden AR; Lindop GB. (Apr 1997). Vascular remodelling in intramyocardial resistance vessels in hypertensive human cardiac transplant recipients. Heart. 77:353-356.
  • Boyle JJ; Jenkins J; McKay IC; McPhaden AR; Lindop GB. (Feb 1997). An assessment of the distortion of arteries due to sectioning in endomyocardial biopsies. J Pathol. 181:243-246. DOI.
  • Jenkins J; Boyle JJ; Moss VA; McPhaden AR; Lindop GB. (Feb 1997). Three-dimensional reconstruction of abnormal intramural coronary arteries in human cardiac allograft biopsies. J Pathol. 181:247-250. DOI.
  • Boyle JJ. (Jan 1997). Association of coronary plaque rupture and atherosclerotic inflammation. J Pathol. 181:93-99. DOI.
  • Boyle JJ; Lawrie G; McPhaden AR; Richens D; Lindop GB. (Nov 1995). Arterial lesions associated with medial disorganization and fibrosis in endomyocardial biopsies from human cardiac allografts. Histopathology. 27:439-444.
  • Lindop GB; Boyle JJ; McEwan P; Kenyon CJ. (Jun 1995). Vascular structure, smooth muscle cell phenotype and growth in hypertension. J Hum Hypertens. 9:475-478.
  • Hamilton CA; Boyle JJ; Huang YT; McCulloch J; Nixon GF; Pryadarshi S. (1994). Agonist desensitisation of alpha 1 adrenoceptors and endothelin-1 receptors coupled to phosphatidylinositol metabolism. Fundam Clin Pharmacol. 8:162-172.

Conferences

  • Sperone A; Dryden N; Birdsey GM; Madden LE; Evans P; Mason JC; Boyle J; Paleolog E; et alHaskard DO; Randi AM. The transcription factor Erg represses ICAM-1 expression and vascular inflammation. 213:E17-E17. (Nov 2010). DOI.
  • Iqbal MB; Johns M; Laffan MA; Haskard DO; Boyle JJ. Dexamethasone reduces monocyte thrombogenecity via tissue factor-dependent and tissue factor-independent pathways. 213:E6-E6. (Nov 2010). DOI.
  • Chaudhury HA; Zakkar M; Boyle J; Dennis J; van der Heiden K; Luong L; Cuhlmann S; Mason JM; et alKrams R; Haskard DO; Evans PC. ENDOTHELIAL CELLS AT ATHEROSUSCEPTIBLE SITES EXPRESS ACTIVATED C-JUN N-TERMINAL KINASE WHICH INDUCES PRO-APOPTOTIC MOLECULES. 95. (15 Nov 2009). DOI.
  • Boyle JJ; Leung VWY; Rizvi H; Evans PC; Haskard DO. MATRIX-BOUND AGGREGATED IGM DRIVES MACROPHAGE CYTOTOXICITY VIA MACROPHAGE SCAVENGER RECEPTOR A AND IS INCREASED IN RUPTURED PLAQUES. 95. (15 Nov 2009). DOI.
  • Boyle JJ; Johns M; Mason JC; Haskard DO. MONOCYTE DIFFERENTIATION TO AN ATHEROPROTECTIVE PHENOTYPE EXPRESSING HEME OXYGENASE-1 PIVOTALLY REQUIRES A HEME-INDUCIBLE TRANS-ACTIVATING FACTOR AND IS COUNTERACTED BY THE NUCLEAR RECEPTOR REVERB. 95. (15 Nov 2009). DOI.
  • Sperone A; Birdsey GM; Dryden N; Evans P; Boyle J; Haskard DO; Mason JC; Randi AM. THE TRANSCRIPTION FACTOR ERG PREVENTS VASCULAR INFLAMMATION BY REPRESSING ICAM-1 EXPRESSION. 95. (15 Nov 2009). DOI.
  • Lewis MJ; Malik TH; Ehrenstein MR; Boyle JJ; Botto M; Haskard DO. IgM deficiency accelerates atherosclerosis: A potential adverse consequence of B cell depletion therapy?. 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals. 58:S934-S934. (Sep 2008).
  • Yeh J; Sennoga C; McConnell E; Eckersley R; Tang M; Dawson D; Boyle J; Seddon J; et alStepney A; Haskard DO; Nihoyannopoulos P. Echo identification and quantification of inflammatory molecules in the heart. 94:A21-A22. (Jul 2008).
  • Lewis MJ; Malik TH; Ehrenstein MR; Boyle JJ; Botto M; Haskard DO. Atheroprotective functions of IgM and complement C1q: do low IgM levels and impaired complement activity provide a new link between atherosclerosis and SLE?. 47:II7-II8. (Apr 2008).
  • Lewis MJ; Malik TH; Ehrenstein MR; Boyle JJ; Botto M; Haskard DO. Serum IgM plays an important protective role in murine atherosclerosis. 193:S3-S4. (Aug 2007). DOI.
  • Steinberg R; Harari OA; Lidington E; Boyle J; Nohadani M; Ohba M; Samarel A; Haskard DO; et alMason JC. Protein kinase C (PKC)epsilon protects human vascular endothelial cells against apoptosis through induction of Bcl-2 and inhibition of caspase-3. 46:I1-I1. (Apr 2007).
  • Yun S; Leung V; Botto M; Haskard DO; Boyle JJ. CD59 protects against lesion formation in LDL receptor deficient mice: Evidence for complement activation in atherogenesis. 93. (Feb 2007).
  • Stangou M; Bhangal G; Lai PC; Smith J; Keith J; Boyle J; Pusey C; Cook T; et alTam F. Interleukin-11 suppressed fibrotic processes in nephrotoxic nephritis in Wistar Kyoto Rats. 21:36-37. (Jul 2006).
  • Boyle JJ; Phiippidis P; Horncastle D; Landis RC; Haskard DO. Vulnerable plaques are characterised by distinct populations of HLADR+/CD163-and HLADR-/CD163+macrophage subtypes. 7:157-157. (Jun 2006).
  • Boyle J; Horncastle D; Philippidis P; Haskard D; Landis R. Proinflammatory and wound-healing macrophages occupy distinct microenvironments within the vulnerable atherosclerotic plaque. 92:A79-A79. (May 2006).
  • Hamdulay SS; Boyle JJ; Lefroy D; Nadra IJ; Mason JC. Hypocomplementaemic urticarial vasculitis complicated by severe valvular heart disease. BSR Annual Meeting/BHPR Spring Meeting. 45:I140-I140. (Apr 2006).
  • Kinderlerer AR; Johns M; Lidington EA; Boyle JJ; Haskard DO; Mason JC. Laminar shear stress upregulates the complement-regulatory protein CD59: A novel cytoprotective mechanism against complement-mediated injury on EC. BSR Annual Meeting/BHPR Spring Meeting. 45:I28-I28. (Apr 2006).
  • Cibrian D; Ajamieh H; Berlanga J; Leon OS; Alba JS; Kim MJT; Marchbank T; Boyle JJ; et alFreyre F; del Barco DG; Lopez-Saura P; Guillen G; Ghosh S; Goodlad RA; Playford RJ. Use of growth hormone releasing peptide-6 for the prevention of hepatic and multi organ failure. Annual Meeting of the British-Society-of-Gastroenterology. 55:A28-A28. (Apr 2006).
  • Bhatia V; Boyle JJ; Roberts CE; Sadler Y; Witztum JL; Benson G; Botto M; Haskard DO. Complement Clq plays a bidirectional role in early atherosclerotic lesions in LDL receptor knock-out mice. 208:31A-31A. (Mar 2006).
  • Boyle JJ. Human macrophages kill human mesangial cells by Fas-L-mediated apoptosis when triggered by antibody via CD16. 208:31A-31A. (Mar 2006).
  • Rizvi H; Horncastle D; Boyle JJ. IgM immunostaining is selectively increased in ruptured human atherosclerotic plaques. 189th Meeting of the Pathological-Society-of-Great-Britain-and-Ireland. 208:5A-5A. (Mar 2006).
  • Philippidis P; Boyle J; Domin J; Nadra I; Haskard DO; Taylor KM; Landis RC. Anti-inflammatory hemoglobin scavenging macrophages in atheroschlerotic plaques: A potential atheroprotective role. 112:U126-U126. (25 Oct 2005).
  • Haskard DO; Bhatia V; Boyle JJ; Mason JC; Botto M. Role of complement and complement regulatory proteins in atherosclerosis. 6:39-39. (Apr 2005).
  • Yeh JS; Tracy S; Drescher KM; Sunde J; Kono K; Chapman N; Boyle J; Hussell T; et alSennoga C; Eckersley R; Blomley M; Haskard D; Nihoyannopoulos P. Expression of E-selectin in coxsackievirus B3 myocarditis. 45:142A-142A. (1 Feb 2005).
  • Landis C; Philippidis P; Boyle JJ; Domin J; Nadra I; Taylor KM; Haskard DO. Hemoglobin scavenging (CD163+) macrophages in atherosclerosis: an anti-inflammatory checkpoint?. 38th Annual Meeting of the Society-for-Leukocyte-Biology. 41-41. (2005).
  • Elkington PT; Emerson JE; Lopez-Pascua LD; O'Kane CM; Horncastle DE; Boyle JJ; Friedland JS. Mycobacterium tuberculosis-infected monocytes drive a matrix degrading phenotype in pulmonary epithelial cells via a p38 switch. 62-63. (2005).
  • Elkington PTG; O'Kane CM; Boyle JJ; Nuttal RK; Edwards DR; Friedland JS. Mechanisms regulating matrix metalloproteinase gene expression and secretion in pulmonary tuberculosis. 59:2-2. (Dec 2004).
  • FitzGerald AJ; Pu M; Marckbank T; Westley BR; May FEB; Boyle J; Yadollahi-Farsani M; Ghosh S; et alPlayford RJ. Synergistic effects of systemic trefoil factor family 1 and epidermal growth factor in a rat model of colitis. 53:A96-A96. (Apr 2004).
  • Elkington PTG; Nutall RK; Boyle JJ; Edwards DR; Friedland JS. Mycobacterium tuberculosis (MTb) stimulates matrix metalloproteinase-1 and-7 expression in human monocytic cells regulated by divergent mechanisms. 37th Annual Meeting of the Society-for-Leukocyte-Biology. 40-40. (2004).
  • Bhatia VK; Boyle JJ; Roberts CE; Grimsditch DC; Sadler Y; Benson G; Botto MB; Haskard DO. Influence of complement C1Q deficiency on early lesion formation in LDL receptor knock-out mice. Joint Meeting of the British-Atherosclerosis-Society/British-Society-for-Haemostasis-and-Thrombosis. 170:S3-S3. (Sep 2003).
  • Charakida A; Seaton ED; Boyle JJ; Stamp G; Ekeowa-Anderson A; Chu AC. A novel case of primary metaplastic carcinoma of the skin. 149:16-16. (Jul 2003).
  • FitzGerald AJ; Marchbank T; Boyle J; Ghosh S; Playford RJ. The nutriceutical bovine colostrum for the treatment of dextran sulfate sodium induced colitis in rats. 52:A64-A64. (Apr 2003).
Share this on DeliciousTweet thisDigg thisStumble thisShare this on Facebook